The timing of dosing of antihypertensive drugs (morning or night) does not affect 24-hour ambulatory blood pressure monitoring (ABPM) levels or quality of life (QoL) in patients with hypertension, the randomized crossover trial HARMONY* has shown.
Subclinical atherosclerosis appears to be associated with glycated haemoglobin A1 in non-diabetic individuals, but only in the presence of carotid plaque, according to a study presented at the International Society of Hypertension (ISH) 2016 meeting in Seoul, Korea.
Effective management of hypertension in developing countries warrants adoption of simplified and accessible treatment interventions adjusted to each country’s condition, inclusive of all stakeholders and with a good policy support, according to an expert who spoke at the International Society of Hypertension 2016 meeting in Seoul, Korea.
Older age, obesity, chronic kidney disease, and diabetes are some of the factors associated with an elevated risk for resistant hypertension, said a specialist at the recent Hypertension Seoul 2016, the 26thScientific Meeting of the International Society of Hypertension.
Silent hypotensive episodes occur with greater frequency in treated than in untreated hypertensive individuals, with the episodes tending to cluster in the morning and late morning (M/LM) hours particularly among older individuals and in the setting of uncontrolled hypertension, according to a study presented at the International Society of Hypertension 2016 meeting in Seoul, Korea.
Almost one in five Singapore adults aged 18–69 years had hypertension, and the dietary intake of sodium chloride (ie, salt) remained high at 8.5 g/day, which exceeded the ≤5.8 g/day of intake recommended by international guidelines, revealed a study presented at the 26th Scientific Meeting of the International Society of Hypertension (ISH 2016) held in Seoul, Korea recently.
There appears to be very low risk of carotid stenosis-associated brain ischaemia relative to risk of stroke by the global burden of atrial fibrillation (AF) in very old treated hypertensive patients, according to a study presented at the International Society of Hypertension (ISH) 2016 meeting in Seoul, Korea.
The complex approach strategy, which includes educational programmes, reminding tips, and state-of-the-art therapy, may significantly increase patient adherence to antihypertensive treatment and improve blood pressure (BP) control in everyday routine practice, according to the PRISMA* study presented at the International Society of Hypertension (ISH) 2016 meeting in Seoul, Korea.
Management of hypertension is all about global cardiovascular risk management and vascular protection, says a renowned cardiologist at Hypertension Seoul 2016, the 26th Scientific Meeting of the International Society of Hypertension. Blood pressure (BP) lowering is the key determinant of treatment benefit.
Central systolic blood pressure (SBP) is more useful than peripheral SBP in identifying heart failure with preserved ejection fraction (HFpEF), although both blood pressure measurements are associated with HFpEF in non-hypertensive patients, according to a study presented at the 26th Scientific Meeting of the International Society of Hypertension (ISH) 2016 in Seoul, Korea.
Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.